ClinicalTrials.gg
RecruitingNCT07299903Updated Dec 23, 2025

IMB-Based Sleep Hygiene Education for Menopausal Women: Effects on Sleep Quality and Depression

An interventional study of Sleep Hygiene Education in Insomnia and Depressive Symptoms, sponsored by Ankara Yildirim Beyazıt University. Recruiting at 1 site in Turkey (Türkiye). Open to female participants aged 45 Years to 60 Years. Per ClinicalTrials.gov, last updated 2025-12-23.

Sponsored by Ankara Yildirim Beyazıt University · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Primary completion was expected by Mar 2026, 8 months ago, but the record still lists the study as recruiting.
Phase
Not applicable
Study type
Interventional
Enrollment
500
Allocation
Randomized
Ages
45 Years to 60 Years
Sex
Female
01

Study summary

This study aims to evaluate the effects of sleep hygiene education on sleep quality and depression in women during menopause. Women will be randomly assigned to either an education group or a control group. The education group will receive training based on the Information-Motivation-Behavioral Skills (IMB) Model. Sleep quality and depression levels will be measured before and after the education. The results will provide insight into whether sleep hygiene education can improve sleep quality and reduce depression in menopausal women.

Read the detailed description

This study aims to evaluate the effects of sleep hygiene education on sleep quality and depression in menopausal women. The study will be conducted in two phases. In the first phase, a menopause-specific sleep quality scale will be developed to assess sleep habits, nighttime awakenings, sleep disruptors, and sleep hygiene behaviors in this population. In the second phase, participants will be randomly assigned to either a control group or an intervention group receiving sleep hygiene education based on the Information-Motivation-Behavioral Skills (IMB) Model. Sleep quality and depression levels will be measured before and after the intervention using validated psychological and physiological assessments. Daily sleep tracking logs will also be used to monitor adherence and intervention effectiveness. The findings will provide insight into whether sleep hygiene education can improve sleep quality and reduce depression among menopausal women, and will serve as a resource for developing nursing interventions and informing health policies.

02

Conditions studied

  • Insomnia
  • Depressive Symptoms

Keywords

  • Menopause
  • Sleep quality
  • Sleep hygiene
  • Depression
  • Women's health
  • Randomized controlled trial
03

In context

Sleep Initiation and Maintenance Disorders

2,722 studies on the registry are indexed under Sleep Initiation and Maintenance Disorders; 726 are open to participants now.

This study's planned enrollment of 500 is above the median of 68 across 2,350 interventional studies indexed under Sleep Initiation and Maintenance Disorders.

Browse Sleep Initiation and Maintenance Disorders studies →

Lead sponsor

Ankara Yildirim Beyazıt University is the lead sponsor of 241 studies on the registry; 54 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
45 Years to 60 Years
Sexes eligible
Female
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Being in menopause
  • Being between 40 and 60 years of age
  • Having a low sleep quality score according to the Menopause-Specific Sleep Quality Scale.
  • Being willing to participate in the study.
  • Having no physical or mental disabilities that would hinder communication.
  • Having technology (smartphone, tablet, or computer) with internet access and the ability to participate in online training.

Exclusion criteria

Exclusion Criteria:

  • Having a history of receiving psychological support.
  • Having been diagnosed with a chronic psychiatric illness (previously diagnosed depression, anxiety disorder, etc.).
  • Having a neurological or chronic systemic illness that may affect sleep quality.
  • Being treated for a sleep disorder (receiving medication or psychotherapy).
  • Receiving hormone replacement therapy (HT).
  • Having received sleep hygiene training/therapy within the last 6 months.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
500 participants (estimated)

Study arms

  • Experimental
    Sleep Hygiene Education

    Participants will receive sleep hygiene education based on the Information-Motivation-Behavioral Skills (IMB) Model. Sleep habits, routines, and behaviors to improve sleep quality will be taught. Sleep quality and depression will be measured before and after the intervention, and participants will maintain daily sleep logs.

    Behavioral: Sleep Hygiene Education

  • No intervention
    Control

    Participants will receive standard care without additional sleep hygiene education. Sleep quality and depression will be measured at the same time points as the intervention group.

Interventions

  • BehavioralSleep Hygiene Education

    Education based on the IMB Model targeting sleep habits, routines, and sleep hygiene behaviors to improve sleep quality.

06

What researchers measure

Primary outcomes

  1. Sleep Quality

    Change in sleep quality measured using the Menopause-Specific Sleep Quality Scale before and after the sleep hygiene education intervention.

    Time frame: Baseline and 10 weeks after intervention

07

Study locations

1 of 1 sites recruiting
  • Ankara Atatürk Sanatorium Training and Research Hospital
    Ankara, Turkey (Türkiye)
    Recruiting
    • Ankara Atatürk Sanatorium Training and Research Hospital · Contactbusrakaragol22@gmail.com · +90 544 574 56 95
    • Aytebn ARIÖZ DÜZGÜN · Contact
08

References and documents

Individual participant data

Plan to share: Yes — IPD Sharing Plan: Yes. De-identified IPD (protocol, SAP, and raw outcome datasets for MSSQS and BDI) will be shared with researchers submitting a methodologically sound proposal. Data will be available starting 9 months post-publication and for 36 months. Access requires a signed Data Access Agreement (DAA). Contact the Principal Investigator at [busrakaragol22@gmail.com] for proposals.

Supporting information: Study protocol, Statistical analysis plan, Informed consent form, Clinical study report, Analytic code

Time frame: Start Date9 months following article publication End Date36 months following article publication

Access criteria: Access is limited to qualified external researchers who submit a methodologically sound research proposal to the Principal Investigator at [busrakaragol22@gmail.com]. Researchers will access de-identified IPD (including MSSQS/BDI data, Protocol, SAP, and Analytic Code). Access is conditional upon two requirements: Execution of a Data Access Agreement (DAA). Provision of ethical approval (IRB/IEC) for secondary analysis from the requester's institution. Data is strictly for non-commercial use.

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 23, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07299903
Responsible party
Sponsor
First posted
Dec 23, 2025
Start date
Jan 1, 2026 (estimated)
Primary completion
Mar 1, 2026 (estimated)
Completion
Jun 30, 2026 (estimated)
Last update
Dec 23, 2025

Study contacts

Busra Karagol
Contact
busrakaragol22@gmail.com
+90 544 574 56 95
Ayten ARIÖZ DÜZGÜN
study director · Ankara Yildirim Beyazıt University

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion